Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy

Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy

To improve the survival of patients with hepatocellular carcinoma (HCC), new biomarkers and therapeutic targets are urgently needed. In this study, the GEO and TCGA dataset were used to explore the differential co-expressed genes and their prognostic correlation between HCC and normal samples. The m...

Full description

Bibliographic Details
Main Authors: Hui-Zhou Li, Qing-Qing Liu, De-Hua Chang, Shu-Xian Li, Long-Tao Yang, Peng Zhou, Jiang-Bei Deng, Chang-Hao Huang, Yu-Dong Xiao
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Biomedicines
Subjects:
hepatocellular carcinoma
NOX4
epithelial–mesenchymal transition
sorafenib resistance
Online Access:https://www.mdpi.com/2227-9059/11/8/2196

Similar Items

Similar Items